The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

The pharmaceutical industry is the cornerstone of drug development, commercialization and marketing. According to Statista, pharma sector revenues topped US$1 trillion for the first time in 2014, and ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in GLP-1s, oncology, and pipeline strength. Strong cash flows and innovation make ...

On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his ...

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 ...

In this article, we will look at the 11 Best Pharma Stocks to Buy According to Hedge Funds. Why is China the Talk of the Town in the Pharma Industry? The US pharmaceutical sector is experiencing a ...

AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. Some pharmaceutical companies dream of developing and launching ...

The global pharmaceutical industry tops $1.2 trillion in sales each year. This huge sector improves the quality of life for many people while creating attractive opportunities for long-term investors.

The global pharmaceutical market reached a total value of US$1.38 trillion in 2024, according to Research and Markets, up significantly from the US$888 billion seen just over a decade earlier in 2010.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...